US Stock MarketDetailed Quotes

ONTXW Onconova Therapeutics, Inc.

Watchlist

0.000
0.0000.00%

Close Nov 22 09:30 ET

0Market Cap0.00P/E (TTM)

Onconova Therapeutics, Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-2.86%-6.65M

-10.77%-23.08M

-2.01%-5.47M

-45.49%-5.76M

-9.61%-5.38M

2.09%-6.46M

8.22%-20.83M

0.91%-5.36M

44.63%-3.96M

-6.16%-4.91M

Net income from continuing operations

7.40%-4.72M

-16.99%-25.16M

-11.87%-6.43M

-35.82%-6.24M

-107.67%-7.4M

33.00%-5.09M

-5.36%-21.5M

-1.70%-5.75M

14.08%-4.6M

17.59%-3.56M

Operating gains losses

909.52%636K

430.16%208K

752.94%145K

88.21%-56K

275.00%56K

-85.25%63K

97.40%-63K

106.20%17K

-268.22%-475K

97.35%-32K

Depreciation and amortization

0.00%3K

-7.14%13K

33.33%4K

--2K

-62.50%3K

-74.55%14K

-72.73%3K

-78.57%3K

--0

Change In working capital

-72.35%-2.64M

556.27%1.49M

166.91%718K

-54.21%440K

226.72%1.86M

-1,679.07%-1.53M

69.35%-327K

40.84%269K

148.39%961K

-333.86%-1.47M

-Change in receivables

-101.89%-1K

196.83%61K

112.00%9K

-100.30%-5K

100.24%4K

--53K

-362.50%-63K

-581.82%-75K

3,422.92%1.69M

-514.57%-1.68M

-Change in prepaid assets

179.31%115K

-166.06%-72K

-88.60%35K

70.40%-37K

202.74%75K

---145K

81.67%109K

579.69%307K

17.22%-125K

-127.14%-73K

-Change in payables and accrued expense

-95.01%-2.7M

1,284.25%1.73M

677.66%731K

198.36%539K

446.29%1.84M

-4,665.52%-1.38M

76.30%-146K

-79.57%94K

69.02%-548K

395.59%337K

-Change in other working capital

0.00%-56K

0.44%-226K

0.00%-57K

0.00%-56K

1.75%-56K

57.57%-227K

70.62%-57K

50.00%-57K

50.44%-56K

Cash from discontinued investing activities

Operating cash flow

-2.86%-6.65M

-10.77%-23.08M

-2.01%-5.47M

-45.49%-5.76M

-9.61%-5.38M

2.09%-6.46M

8.22%-20.83M

0.91%-5.36M

44.63%-3.96M

-6.16%-4.91M

Investing cash flow

Cash flow from continuing investing activities

72.73%-15K

-55K

-56K

Net PPE purchase and sale

----

72.73%-15K

--0

----

---55K

--1K

---56K

--0

Cash from discontinued investing activities

Investing cash flow

----

72.73%-15K

--0

----

---55K

--1K

---56K

--0

Financing cash flow

Cash flow from continuing financing activities

141.18%35.64M

-27.36%19.36M

-98.80%279K

-8.45%2.72M

304.35%1.58M

44,684.85%14.78M

-25.27%26.65M

23.26M

2.97M

-98.55%391K

Net common stock issuance

287.85%35.15M

-58.35%9.06M

--0

--9.06M

-37.95%21.76M

--18.4M

--2.97M

-98.52%391K

Proceeds from stock option exercised by employees

-91.31%497K

110.57%10.3M

-94.25%279K

--2.72M

--1.58M

17,224.24%5.72M

730.05%4.89M

--4.86M

--0

Cash from discontinued financing activities

Financing cash flow

141.18%35.64M

-27.36%19.36M

-98.80%279K

-8.45%2.72M

304.35%1.58M

44,684.85%14.78M

-25.27%26.65M

--23.26M

--2.97M

-98.55%391K

Net cash flow

Beginning cash position

-16.29%19.03M

33.92%22.73M

401.93%24.2M

362.90%27.23M

198.54%31.04M

33.92%22.73M

321.72%16.97M

-78.46%4.82M

-80.09%5.88M

43.12%10.4M

Current changes in cash

248.68%29M

-164.79%-3.73M

-129.00%-5.19M

-190.55%-3.05M

15.56%-3.82M

226.61%8.32M

-55.54%5.76M

430.86%17.9M

85.35%-1.05M

-120.27%-4.52M

Effect of exchange rate changes

-166.67%-16K

633.33%32K

77.78%16K

215.38%15K

75.00%7K

0.00%-6K

60.00%-6K

280.00%9K

-550.00%-13K

125.00%4K

End cash Position

54.68%48.01M

-16.29%19.03M

401.93%24.2M

362.90%27.23M

198.54%31.04M

33.92%22.73M

-78.46%4.82M

-80.09%5.88M

Free cash flow

-2.86%-6.65M

-10.55%-23.09M

-2.03%-5.47M

-43.47%-5.76M

-9.92%-5.4M

2.09%-6.46M

7.97%-20.89M

0.92%-5.36M

43.85%-4.02M

-6.16%-4.91M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-2.86%-6.65M	-10.77%-23.08M	-2.01%-5.47M	-45.49%-5.76M	-9.61%-5.38M	2.09%-6.46M	8.22%-20.83M	0.91%-5.36M	44.63%-3.96M	-6.16%-4.91M
Net income from continuing operations	7.40%-4.72M	-16.99%-25.16M	-11.87%-6.43M	-35.82%-6.24M	-107.67%-7.4M	33.00%-5.09M	-5.36%-21.5M	-1.70%-5.75M	14.08%-4.6M	17.59%-3.56M
Operating gains losses	909.52%636K	430.16%208K	752.94%145K	88.21%-56K	275.00%56K	-85.25%63K	97.40%-63K	106.20%17K	-268.22%-475K	97.35%-32K
Depreciation and amortization	0.00%3K	-7.14%13K	33.33%4K	33.33%4K	--2K	-62.50%3K	-74.55%14K	-72.73%3K	-78.57%3K	--0
Change In working capital	-72.35%-2.64M	556.27%1.49M	166.91%718K	-54.21%440K	226.72%1.86M	-1,679.07%-1.53M	69.35%-327K	40.84%269K	148.39%961K	-333.86%-1.47M
-Change in receivables	-101.89%-1K	196.83%61K	112.00%9K	-100.30%-5K	100.24%4K	--53K	-362.50%-63K	-581.82%-75K	3,422.92%1.69M	-514.57%-1.68M
-Change in prepaid assets	179.31%115K	-166.06%-72K	-88.60%35K	70.40%-37K	202.74%75K	---145K	81.67%109K	579.69%307K	17.22%-125K	-127.14%-73K
-Change in payables and accrued expense	-95.01%-2.7M	1,284.25%1.73M	677.66%731K	198.36%539K	446.29%1.84M	-4,665.52%-1.38M	76.30%-146K	-79.57%94K	69.02%-548K	395.59%337K
-Change in other working capital	0.00%-56K	0.44%-226K	0.00%-57K	0.00%-57K	0.00%-56K	1.75%-56K	57.57%-227K	70.62%-57K	50.00%-57K	50.44%-56K
Cash from discontinued investing activities
Operating cash flow	-2.86%-6.65M	-10.77%-23.08M	-2.01%-5.47M	-45.49%-5.76M	-9.61%-5.38M	2.09%-6.46M	8.22%-20.83M	0.91%-5.36M	44.63%-3.96M	-6.16%-4.91M
Investing cash flow
Cash flow from continuing investing activities		72.73%-15K	0	0			-55K	1K	-56K	0
Net PPE purchase and sale	----	72.73%-15K	--0	--0	----	----	---55K	--1K	---56K	--0
Cash from discontinued investing activities
Investing cash flow	----	72.73%-15K	--0	--0	----	----	---55K	--1K	---56K	--0
Financing cash flow
Cash flow from continuing financing activities	141.18%35.64M	-27.36%19.36M	-98.80%279K	-8.45%2.72M	304.35%1.58M	44,684.85%14.78M	-25.27%26.65M	23.26M	2.97M	-98.55%391K
Net common stock issuance	287.85%35.15M	-58.35%9.06M	--0	--0	--0	--9.06M	-37.95%21.76M	--18.4M	--2.97M	-98.52%391K
Proceeds from stock option exercised by employees	-91.31%497K	110.57%10.3M	-94.25%279K	--2.72M	--1.58M	17,224.24%5.72M	730.05%4.89M	--4.86M	--0	--0
Cash from discontinued financing activities
Financing cash flow	141.18%35.64M	-27.36%19.36M	-98.80%279K	-8.45%2.72M	304.35%1.58M	44,684.85%14.78M	-25.27%26.65M	--23.26M	--2.97M	-98.55%391K
Net cash flow
Beginning cash position	-16.29%19.03M	33.92%22.73M	401.93%24.2M	362.90%27.23M	198.54%31.04M	33.92%22.73M	321.72%16.97M	-78.46%4.82M	-80.09%5.88M	43.12%10.4M
Current changes in cash	248.68%29M	-164.79%-3.73M	-129.00%-5.19M	-190.55%-3.05M	15.56%-3.82M	226.61%8.32M	-55.54%5.76M	430.86%17.9M	85.35%-1.05M	-120.27%-4.52M
Effect of exchange rate changes	-166.67%-16K	633.33%32K	77.78%16K	215.38%15K	75.00%7K	0.00%-6K	60.00%-6K	280.00%9K	-550.00%-13K	125.00%4K
End cash Position	54.68%48.01M	-16.29%19.03M	-16.29%19.03M	401.93%24.2M	362.90%27.23M	198.54%31.04M	33.92%22.73M	33.92%22.73M	-78.46%4.82M	-80.09%5.88M
Free cash flow	-2.86%-6.65M	-10.55%-23.09M	-2.03%-5.47M	-43.47%-5.76M	-9.92%-5.4M	2.09%-6.46M	7.97%-20.89M	0.92%-5.36M	43.85%-4.02M	-6.16%-4.91M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data